Caricamento...
Targeting nanomedicines in the treatment of rheumatoid arthritis: focus on certolizumab pegol
Anti-TNFα therapy has revolutionized the treatment of rheumatoid arthritis (RA) and other inflammatory diseases. These drugs are powerful and expensive. A new anti-TNFα agent, a nanomolecule comprising a humanized Fab’ antibody fragment against TNFα with a polyethylene glycol tail, is shortly to com...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove Medical Press
2007
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2673817/ https://ncbi.nlm.nih.gov/pubmed/17722505 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|